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Abstract
The causes of early genomic events underlying the
development of prostate cancer (CaP) remain unclear.
The onset of chromosomal instability is likely to
facilitate the formation of crucial genomic aberrations
both in the precursor lesion high-grade prostatic intra-
epithelial neoplasia (HPIN) and in CaP. Instability
generated by telomere attrition is one potential mech-
anism that could initiate chromosomal rearrange-
ments. In this study, normalized telomere length
variation was examined in a cohort of 68 men without
CaP who had HPIN only on prostatic biopsies. Multiple
significant associations between telomere attrition
and eventual diagnosis of CaP in the HPIN and in the
surrounding stroma were found. Kaplan-Meier analysis
of telomere length demonstrated a significantly in-
creased risk for the development of cancer with short
telomeres in the surrounding stroma [P = .035; hazard
ratio (HR) = 2.12; 95% confidence interval (95% CI) =
0.231–0.956], and a trend for HPIN itself (P = .126; HR =
1.72; 95% CI = 0.287–1.168). Cox regression analysis
also demonstrated significance between the time from
the original biopsy to the diagnosis of cancer and
telomere length in HPIN and in the surrounding stroma.
These analyses showed significance, both alone and in
combination with baseline prostate-specific antigen,
and lend support to the hypothesis that telomere
attrition in prostatic preneoplasia may be fundamental
to the generation of chromosomal instability and to the
emergence of CaP.
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Introduction
Prostate cancer (CaP) is the most commonly diagnosed malig-
nancy in men, with over a quarter of a million cases expected to
be diagnosed in North America in 2006 [1,2]. However, an
understanding of critical steps in themolecular and pathological
etiologies of early prostatic carcinogenesis has not yet been
achieved. Currently, the precursor lesion, high-grade prostatic
intraepithelial neoplasia (HPIN), is considered the most likely
preneoplastic precursor to CaP based on pathological [3],
epidemiological [4,5], and molecular evidence [6]. The latter
is especially suggestive of an association between the two
lesions, with analyses of coexistent HPIN and CaP demons-
trating similar chromosomal abnormalities, such as the char-
acteristic loss of chromosome 8p and gain of chromosomes
8q, 7, 10q, and 16q, suggesting the emergence of chromosomal
instability in HPIN [7]. Instability generated by telomere attri-
tion in prostatic preneoplasia [8–10] is one mechanism that
could facilitate the acquisition of consistent chromosomal re-
arrangements observed in HPIN [11,12].
Telomeres and associated nucleoprotein complexes are the
terminal ends of eukaryotic chromosomes and contain up to
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2000 repeats of the sequence TTAGGG [13]. Their primary
role is to ensure chromosomal integrity by preventing the
recognition of chromosome ends as DNA double-strand
breaks, thus preventing recombination and leading to a cel-
lular senescence response [14]. Telomere attrition and dys-
function may be due to several mechanisms such as the
end-replication problem of chromosomal ends [15], which
is believed to provide cells with a ‘‘mitotic clock’’ that limits
cellular proliferation, thereby acting as a tumor-suppressor
mechanism. However, continued cellular proliferation in the
presence of shortened or dysfunctional telomeres results in
end fusions and onset of chromosomal instability through
break–fusion–bridge cycles [16]. Although these rearrange-
ments are likely to lead to cell death, some surviving cells
are thought to emerge, which eventually both stabilize their
telomere lengths and control their level of instability through
the reexpression of an enzyme called telomerase [17]. Telo-
merase adds telomeric sequence DNA to chromosomes
and is expressed at varying levels in HPIN and at high levels
in CaP [18–20]. The expression of telomerase and the ac-
quisition of genomic alterations commonly observed in CaP,
such as TMPRSS2–ETS fusion [21,22] and PTEN loss [12],
are likely to be crucial to the subsequent progression of
CaP from HPIN.
Up to 80% of CaP is both multifocal and associated with
HPIN, suggesting a field effect of cancerization in the pe-
ripheral zone of the prostate, where these cancers are com-
monly found [23]. The molecular nature of this field effect
is thought to involve only the prostatic epithelium. We rea-
soned that telomere length in the prostatic stroma may also
be altered in the peripheral zone for two reasons. Firstly,
etiologic agents involved in prostatic carcinogenesis may
affect telomeres in the whole gland rather than in the epithe-
lium only. Alternatively, it is conceivable that inheritance of
shorter constitutional telomere length may itself be a risk
factor for neoplastic progression in the prostate, as has been
shown in other malignancies [24]. To explore these con-
cepts, we examined normalized telomere length in a cohort
of men who had isolated HPIN on prostatic biopsies with
follow-up of up to 5.5 years. In this study, the amount of telo-
meric attrition in HPIN was accompanied by a proportional
shortening in the surrounding stroma. We conclude that the
extent of telomere attrition in such tissues may allow for
improved prognostication of HPIN lesions into low or high
risk for the development of eventual CaP, and may provide




Patient samples used in this study comprised a retro-
spective cohort derived from prostatic biopsies obtained
through the UroPath Canadian Pathology Speciality Services
over the period 1998 to 2000. The Research Ethics Board of
the University Health Network (Toronto, Ontario, Canada)
approved this study.
Description of Cohort
The characteristics of the cohort are described in Table 1.
Men were biopsied using a sextant technique with six pos-
sible sites for biopsy. Seven of 34 (21%) men had the cancer
diagnosed at the site of the HPIN biopsy available for the
study; 12 of 34 (35%) had cancer diagnosed on the same
side, whereas 19 of 34 (56%) had cancer diagnosed on the
opposite side.
Pathology
Biopsy samples were formalin-fixed and paraffin-
embedded. One biopsy per subject was analyzed. The bi-
opsies usually consisted of a slither of tissue (approximately
1–2 mm by up to 15 mm). The initial cohort comprised
94 patients, all of whom had a recorded diagnosis of HPIN
on the initial pathology review of prostatic biopsies. Following
reevaluation of deeper sections by one of the authors (A.E.),
a cohort of 68 patients who had evidence of HPIN and
adequate stroma on deeper sectioning was identified for
inclusion into this study. There were two to four deeper slides
available from the original hematoxylin and eosin (H&E) slide
used for HPIN identification, orientation, and further analy-
ses. These regions and the surrounding areas of matching
stroma were examined for telomeric and centromeric con-
tent using quantitative fluorescence in situ hybridization
(QFISH). All investigators were blinded to patient outcome
during the study period.
QFISH
QFISH was performed using pan-telomeric and pan-
centromeric peptide nucleic acid (PNA) probes on unstained
5-mm sections. Telomere (C3TA2)3–specific and centromere
(16-mer a repeat DNA)–specific [25] probes were directly
labeled with Cy3 and fluorescein isothiocyanate (FITC) fluo-
rescent dyes, respectively, and were obtained from Applied
Biosystems (Foster City, CA). The standard technique for
PNA FISH [26] was applied with minor modifications, as de-
scribed previously [8]. Slides were counterstained with DAPI/
antifade (Vectashield, Burlingame, CA) and analyzed.
Image Capturing
Regions of interest were identified and marked on an
overlying H&E section. Corresponding pathology was identi-
fied on FISH slides. The slides were analyzed with a Leica
DMRA2 epifluorescence microscope (Leica Microsystems,
Table 1. Description of Study Cohort.
Average SD Median Range
PSA 8.8 6.95 8 0.7–51
Age 66 years 6.7 67 51–82
Time from first biopsy
to final biopsy
18.82 months 16.52 14.5 1–69
Time to diagnosis of
cancer (n = 34)
15.5 months 11.87 14 1–42
Number of biopsies
until cancer was
diagnosed (n = 34)
1.47 0.92 1 1–5
Gleason score (n = 34) 6.26 0.56 6 5–8
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Wetzlar, Germany) equipped with appropriate filter sets, a
mercury lamp, and a 100/1.4-NA oil immersion lens.
Twelve-bit grey-scale images were produced with a Hama-
tasu ORCA ER-17 camera (Hamatasu, Bridgewater, NJ) and
OpenLab 4.0.3 software package (Improvision, Lexington,
MA). To compensate for different focal depths, 10 con-
secutive images were z-stacked with an automated Leica
CTRMIC interface (Leica Microsystems) into a composite
image that was used for quantification. Images were saved
and exported to the Image J software package [27]. Exposure
times were optimized with respect to the intensities of telo-
mere and centromere signals to prevent the overexposure/
saturation of signals in the original and stacked images. Once
optimization times had been determined, they were kept
constant for all analysis experiments. Fluorescence output
was verified to be within the linear range of assessment. An
average of 50 cells from eachHPIN and stroma on every slide
was examined to quantify telomeric and centromeric signals
with QFISH. Stromal cells were taken in random locations
surrounding the HPIN gland identified for imaging. An optimal
region for analysis was selected, avoiding areas of photo-
bleaching and lipofuscin autofluorescence, typically within
1 mm of HPIN.
Image Assessment
Quantitative assessment of telomere/centromere signal
intensity was performed on captured images and used to
determine relative changes in telomere length and DNA
ploidy. The original 12-bit images were exported to Image J.
Initially, nonoverlapping nuclei were defined in a region-of-
interest file. Subsequently, quantitative analysis was per-
formed on a per-nuclear basis on Cy3 (telomere) and FITC
(pan-centromere) images using visual thresholding to out-
line relevant signals [28]. The intensities of all pixels out-
lined within a predefined nuclear boundary were summed
on a per-cell basis and tabulated. Absolute values for pan-
centromeric QFISH indicate partial ploidy change, poly-
somies, hybridization differences, or amounts of nuclear
material in a section. For example, theoretically, there will
be a doubling of telomere signal per centromere as a result of
every extra chromosome per HPIN cell. Thus, to control for
ploidy and hybridization differences, all telomere intensities
were expressed as telomeric intensity/centromere intensity
ratios for each nucleus. These ratios were then averaged
across the whole slide. An example of the approach taken in
this study is illustrated in Figure 1.
Statistical Assessment
All statistical assessments were carried out with the ‘‘R’’
software package [29]. All correlations were examined with
normalized telomere lengths. Statistical analyses for corre-
lations for CaP outcome were carried out for significance
using logistic regression and likelihood ratio tests. Standard
t-tests were used to detect differences between mean telo-
mere values of men who developed cancer and men who did
not develop cancer. Cox regression modeling was used to
determine the association of time to diagnosis with normal-
ized telomere length, as well as the calculation of hazard
ratios (HRs) and confidence intervals for Kaplan-Meier anal-
ysis. Standard Kaplan-Meier analysis was carried out to




Absolute fluorescence values Total centromeric intensity
in HPIN, compared to total centromeric intensity in the
surrounding stroma, revealed an average increase of 22%
in centromeric fluorescence (SD = 31%) (Figure 2A). In com-
parison, absolute telomeric intensity measured in HPIN di-
vided by that in the surrounding stroma revealed that the
telomeres in HPIN were, on average, 36% of those in the
surrounding stroma (SD = 21%) (Figure 2B).
Normalized fluorescence values Inspection of normalized
QFISH values alone for both HPIN and stroma did not re-
veal any population of uniform telomere length among cells
(Figure 2, C and D). There did not appear to be any relation-
ship between telomere length in HPIN or in the stroma and
patient age on initial biopsy (adjusted R2 = 0.052 and 0.104,
respectively). Additionally, there was also no correlation
between prostate-specific antigen (PSA) level and telomere
length, suggesting that these may be independent phe-
nomena (adjusted R2 = 0.007 and 0.006, respectively).
The most notable finding was the relationship found between
the stroma and the epithelium. There appeared to be a
significant association between the telomere length in the
HPIN and that in the surrounding stroma (adjusted R2 =
0.4697; P = 1.14  1010) (Figure 4A).
Statistical Correlations
Analysis for CaP outcome As the cohort of men did not
have time-mandated or event-mandated biopsies, we initially
calculated logistic regression statistics for the diagnosis of
CaP after particular time points had elapsed. The time vari-
able corrects for men who were lost to follow-up after a nega-
tive biopsy subsequent to the time indicated in Table 2.
Multivariate modeling at these time points, combining telo-
mere length measurements and PSA, also showed high
levels of significance (e.g., 3 months: PSA + HPIN, P =
.019; PSA + stroma, P = .015). P values calculated for the
association between telomere length and PSA by logistic
and multivariate analyses are presented in Table 2. Alter-
natively, standard t-test analyses and accompanying box-
plots for telomere length in both HPIN [t-test: P = .03; 95%
confidence interval (95% CI) = 0.004–0.080] and stroma
(t-test: P = .04; 95% CI = 0.004–0.188) with the final
diagnoses are illustrated in Figure 3, A and B.
Cox regression modeling for time to diagnosis Cox re-
gression modeling demonstrated that the telomere length of
HPIN and of the surrounding stroma also predicted the time to
diagnosis of cancer from initial biopsy, both alone (P = .015
and P = .021, respectively) and in combination with PSA
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(HPIN+PSA:P = .006; stroma+PSA:P = .010; PSA+HPIN+
stroma: P = .015).
Site of cancer and Gleason score There did not appear
to be any relationship between the telomere length of bi-
opsy and the ultimate Gleason score of prostate tumors
(Figure 4B). To determine whether the relative telomere
length within different regions of the gland at the time of
biopsy was predictive of the site that was subsequently
diagnosed with cancer, a comparison between the actual
sites biopsied and the side of the gland that was diagnosed
with cancer was performed (Figure 4C). Although the num-
bers are limited, trends in both HPIN and stromal telomere
length suggest that attrition in biopsy sites that eventually
had cancer detected were indeed shorter than the attrition
in biopsy sites where cancer was detected on the same side
but at a different site or on the opposite side of the gland.
Analyses from Stratification of Telomere Length
As a further exploratory analysis, telomere length was
stratified into ‘‘short’’ and ‘‘long’’ based on the statistical
standard of median values. Kaplan-Meier analysis of the
time to diagnosis of cancer stratified by telomere length in
HPIN reveals a trend to significance (P = .126; HR = 1.72;
95% CI = 0.287–1.168); however, a similar analysis of
telomere length in stroma reveals a significant finding
(P = .0346; HR = 2.12; 95% CI = 0.231–0.956) (Figure 3,
C andD). A trend was also noted for PSA (P = .093; HR = 1.8;
95% CI = 0.892–3.632), but not for age (P = .522; HR = 0.8;
95% CI = 0.632–2.570).
Discussion
Understanding the molecular processes driving prostatic
carcinogenesis has important clinical consequences, as
HPIN biopsy and autopsy studies [30] suggest that PIN
may precede cancer by about a decade. Previously, our
laboratory demonstrated a decline in telomere length in
radical prostatectomy samples in the progression from be-
nign epithelium to HPIN far from the cancer, to HPIN close to
the cancer, to CaP itself [8]. The present QFISH study
appears to be the first to examine normalized telomere length
measurements using cell-by-cell analyses of both preneo-
plastic epithelial tissues and stromal components of the
prostate in a large-enough cohort to detect a correlation
between epithelial and stromal telomere lengths (Figure 1).
The detailed results presented herein reveal interesting
insights concerning both telomere biology and the process of
prostatic preneoplasia. The 22% increase in centromeric
material in HPIN compared to that in the stroma (Figure 2A)
Figure 1. A representative example of the analysis used in HPIN biopsies. (A) Areas of interest were identified and corresponding QFISH images were generated
on a deeper slice of the tissue, with corresponding areas of stroma (B) and HPIN (C) analyzed. The images have been colored to facilitate visual inspection with
telomere PNA probe (Cy3—red) and centromere PNA probe (FITC—green).
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is consistent with previous studies from our laboratory, indi-
cating that, in early HPIN, gross ploidy change is rare,
although subsets of patients have characteristic chromo-
somal gains [7]. The 64% reduction in telomere length in
the same tissue (Figure 2B) may simply be a surrogate
marker for the number of times that the preneoplastic epi-
thelium, compared to the surrounding stroma, has replicated.
However, a number of factors may also influence telomere
length because ploidy change, concurrent telomerase ex-
pression [19,20], and additive oxidative stress [31] are all
likely to influence the relative rates of attrition. Importantly,
the findings of the present study are coherent with that of
Meeker et al., who examined 11 HPIN lesions from six pa-
tients after radical prostatectomy. Similar telomeric fluores-
cence in prostatic stromal and basal epithelial cells was
found, with a 3.7-fold (or 73%) decrease in luminal HPIN
compared to that in basal cells—comparable to our finding
of a 2.8-fold (or 64%) decrease compared to that in the
surrounding stroma.
Overall, the data suggest that those men with biopsies
with shorter telomeres have features that either directly or
indirectly lead to a greater likelihood of a diagnosis of cancer.
Shorter telomeres may either have been inherited as a
constitutional trait or have been acquired somatically be-
cause of attrition induction by tissue-specific environmental
factors. In either case, in HPIN lesions bearing longer telo-
meres, they may have been acting initially as a tumor-
suppressor mechanism, as prostatic epithelial cells do not
possess enough permissive mutations for continued pro-
liferation to take place in the setting of a telomere-induced
DNA damage signal [10]. Current models suggest that if
Figure 2. To examine the relative amount of chromosomal material in the HPIN versus the amount of chromosomal material in the surrounding stroma, we plotted
(A) the frequency distribution of the ratio of centromeric fluorescence intensity measurements in HPIN compared to that in the surrounding stroma. An average
increase of 22% (SD 31%) was found in HPIN compared to that found in the surrounding stroma. To examine the relative amount of telomere attrition in the
prostate, we plotted (B) the frequency distribution of the ratio of the telomeric fluorescence in HPIN divided by that in the surrounding stroma. As mentioned in the
text, an average 64% decrease of the surrounding stroma (SD = 21%) was found. (C) Frequency distribution of normalized telomere values (telomeric
fluorescence/centromeric fluorescence) in the HPIN and (D) in the stroma of the study cohort.








Immediately 68 .026 .029 .021 .012 .010
3 months 64 .050 .038 .032 .019 .015
6 months 61 .075 .046 .046 .036 .026
12 months 56 .056 .043 .107 .049 .046
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continued proliferation occurs, telomere lengthmay simply be
acting as a mitotic clock. It follows that areas of HPIN with
shorter telomeres will have replicated more and will have had
a greater opportunity to accumulate stochastic events that
ultimately lead to genomic instability and acquisition of chro-
mosomal rearrangements associated with the emergence
of carcinoma [8].
Alternatives to this model involve an appreciation of
cellular senescence phenomena. Senescence in the setting
of preneoplasia is thought to occur due to either telomere
attrition eliciting a DNA damage response or inappropriate
oncogene activation, likely through p16 [32]. Thus, certain
HPIN lesions (presumably those with longer telomeres)
may be arrested due to oncogene-induced senescence—a
phenomenon that has received a great deal of interest re-
cently [33]. Those HPIN cells with relatively short telo-
meres will presumably lack the molecular machinery to
elicit an oncogene-induced senescence response. Eventu-
ally, telomere-generated chromosomal instability is likely
to occur, leading to the onset of neoplasia. Senescence
phenomena are currently relatively poorly understood in
prostatic carcinogenesis [34]. Two recent papers have pro-
vided support for the role of oncogene-induced senescence
in this context. Fan et al. [35] demonstrated high levels of
Figure 3. (A) Boxplot of relative telomere length in HPIN comparing groups of men who developed cancer and men who did not develop cancer. The thick black line
represents median values. The upper border of the blue rectangle represents the 25th percentile, and the lower border represents the 75th percentile. Circles
represent outliers based on 1.5 interquartile range. Bars extending above and below represent the upper and lower limits of data (t-test: P = .03; 95% CI = 0.004–
0.080). (B) Boxplot of relative telomere length in the stroma comparing groups of men who developed cancer and men who did not develop cancer. Boxplot
variables and numbers are similar to (A) (t-test: P = .04; 95% CI = 0.004–0.188). (C) Kaplan-Meier analysis of HPIN telomere length, stratified by the median value
for the time to develop cancer ( P = .126; HR = 1.72; 95% CI = 0.287–1.168). (D) Kaplan-Meier analysis of stromal telomere length, stratified by the median value
for the time to develop cancer ( P = .0346; HR = 2.12; 95% CI = 0.231–0.956).
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Figure 4. (A) Relationship between normalized HPIN and stromal telomere length in prostatic biopsies examined. Normalized telomere length reflects telomere
intensities controlled for centromeric intensities. R2 values are indicated. (B) Boxplots of normalized telomere lengths in HPIN and in the stroma, according to the
Gleason score of eventual cancer. Because of limited numbers, cases were grouped according to low (5–6) and high Gleason scores (6–7). Numbers in brackets
adjacent to labels on the x-axis represent the number of cases with that outcome in the cohort. Boxplot variables and numbers are similar to those in Figure 3 A. (C)
Boxplots represent sites of diagnosis of CaP grouped by their relationship to where the biopsy was analyzed. Boxplot variables and numbers are similar to those in
Figure 3 A. X-axis labels refer to the type of analysis: either HPIN or surrounding stroma, with the preceding letters referring to the site of the eventual cancer; either
the same site, the same side, or the opposite side of the prostate gland. Numbers in brackets refer to the number of men in those groups.
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activated ATM and other proteins involved in DNA damage
response in HPIN, whereas a PTEN knockout model of
CaP found heterozygous PTEN deletion leading to a p53-
dependent senescence barrier that would likely be prema-
ture for a telomere-induced barrier and also limited staining
of human HPIN lesions with b-galactosidase, a traditional
marker of senescent cells [36].
Current evidence suggests that histologically normal
prostatic tissues adjacent to a CaP may harbor subtle onco-
genic changes [37–39]; however, there are only limited
data suggesting that the surrounding stroma is also subject
to oncogenic modification [40]. Preliminary evidence of such
a phenomenon was first reported by Fordyce et al. [37] who
found reduced telomere length in histologically normal pros-
tate tissues (containing both the epithelium and the stroma)
in tissues adjacent to the foci of CaP. The finding presented
in the present study, indicating that telomere attrition is partly
attributable to the stroma alone, has important implications.
Firstly, as the prostatic stroma is not thought to replicate to
any significant degree during the process of prostatic carci-
nogenesis, these data suggest that etiologic factors postu-
lated to be related to prostatic carcinogenesismay affect both
compartments of the prostatic microarchitecture. Dietary
antioxidant deficiency and chronic inflammation are consid-
ered candidates for this effect, as they both act through
oxidative stress, to which telomeres are known to be partic-
ularly susceptible [41,42]. Secondly, corroborative evidence
[43] suggests that senescent prostatic fibroblasts (which
are likely to be those with short telomeres) secrete a number
of growth factors, such as hepatocyte growth factor (HGF),
that may facilitate prostatic carcinogenesis through mecha-
nisms such as coactivation of androgen receptor signaling
[44]. Taken together, these studies suggest a link between
the well-established role of tumor–stromal interaction [45]
and telomere dysfunction in prostatic carcinogenesis.
Despite the intriguing observations made, there are limi-
tations to this analysis. The patient biopsies originated
from different community practices throughout Ontario,
Canada, and did not have consistent time-mandated or
event-mandated biopsies. We were limited in only analyzing
one HPIN-containing biopsy site in the sextant biopsy set
from every man, rather than a more thorough analysis of
telomere length in every biopsy site, which would allow a
greater understanding of the evolution of telomere dysfunc-
tion in the three-dimensional anatomy of the prostate gland.
Additionally, ascertaining telomerase expression would have
been useful in our cohort; however, there are currently no
reliable methodologies to do this in paraffin-embedded sec-
tions [46]. Unfortunately, normal peripheral blood was not
available to further explore the contribution of constitutional
telomere length in this study. Finally, it is possible that a
proportion of the men who were diagnosed with CaP during
the study period had foci of neoplasia that were missed on
initial biopsy.
In conclusion, there are a number of emerging markers of
CaP in progress [47,48]. This study suggests that telomere
attrition analysis may assist with diagnosis and prognosis in
prostatic neoplasia.
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